Literature DB >> 8991641

Purification and seroreactivity of pneumococcal surface adhesin A (PsaA).

J A Tharpe1, H Russell.   

Abstract

Pneumococcal surface adhesin A (PsaA) is a 37-kDa common protein antigen of Streptococcus pneumoniae. In the present study, the protein was purified so that its immunoreactivity could be determined. PsaA was released and purified from cells by lysis in the presence of n-laurylsarcosine; this was followed by ammonium sulfate precipitation and subsequent preparative isoelectric focusing. A capture antibody enzyme-linked immunosorbent assay was used to determine the immunoreactivity of purified PsaA. The assay had a 67% sensitivity for sera from patients with bacteremic pneumococcal pneumonia. A specificity of 97% was estimated on the basis of a lack of reactivity with sera from patients with pneumonia caused by other organisms. PsaA is a potential vaccine candidate and may be useful as an antigen in a diagnostic assay for pneumococcal disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8991641      PMCID: PMC170284          DOI: 10.1128/cdli.3.2.227-229.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  15 in total

1.  Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae.

Authors:  H Russell; J A Tharpe; D E Wells; E H White; J E Johnson
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

Review 2.  Antigen detection in pneumococcal pneumonia.

Authors:  M Farrington; D Rubenstein
Journal:  J Infect       Date:  1991-09       Impact factor: 6.072

Review 3.  Current trends in bacterial respiratory pathogens.

Authors:  R R Facklam; R F Breiman
Journal:  Am J Med       Date:  1991-12-30       Impact factor: 4.965

4.  Immunologic characterization and specificity of three monoclonal antibodies against the 58-kilodalton protein of Legionella pneumophila.

Authors:  J S Sampson; B B Plikaytis; C H Aloisio; G M Carlone; C P Pau; A R Stinson
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

5.  Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. adhesins.

Authors:  J S Sampson; S P O'Connor; A R Stinson; J A Tharpe; H Russell
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

6.  Free-solution isoelectric focusing for the purification of Staphylococcus aureus enterotoxin C1.

Authors:  N L St Clair; M Sax
Journal:  Protein Expr Purif       Date:  1990-11       Impact factor: 1.650

Review 7.  Immunization policies and vaccine coverage among adults. The risk for missed opportunities.

Authors:  W W Williams; M A Hickson; M A Kane; A P Kendal; J S Spika; A R Hinman
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

8.  Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide.

Authors:  J C Paton; R A Lock; C J Lee; J P Li; A M Berry; T J Mitchell; P W Andrew; D Hansman; G J Boulnois
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

9.  Pneumonia: a deadly disease despite intensive care treatment.

Authors:  J Sörensen; I Cederholm; C Carlsson
Journal:  Scand J Infect Dis       Date:  1986

10.  Preparative free solution isoelectric focusing of human erythrocyte uroporphyrinogen I synthase in an ampholyte pH gradient.

Authors:  J Veser
Journal:  Anal Biochem       Date:  1989-11-01       Impact factor: 3.365

View more
  7 in total

1.  Diagnosis of invasive pneumococcal disease among children in Kenya with enzyme-linked immunosorbent assay for immunoglobulin G antibodies to pneumococcal surface adhesin A.

Authors:  J Anthony G Scott; Zena Mlacha; Joyce Nyiro; Salome Njenga; Pole Lewa; Jacktone Obiero; Hanningtone Otieno; Jacquelyn S Sampson; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

2.  Limited diversity of Streptococcus pneumoniae psaA among pneumococcal vaccine serotypes.

Authors:  J S Sampson; Z Furlow; A M Whitney; D Williams; R Facklam; G M Carlone
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

3.  Immunoreactivity of five monoclonal antibodies against the 37-kilodalton common cell wall protein (PsaA) of Streptococcus pneumoniae.

Authors:  J Crook; J A Tharpe; S E Johnson; D B Williams; A R Stinson; R R Facklam; E W Ades; G M Carlone; J S Sampson
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

Review 4.  Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).

Authors:  D E Briles; R C Tart; E Swiatlo; J P Dillard; P Smith; K A Benton; B A Ralph; A Brooks-Walter; M J Crain; S K Hollingshead; L S McDaniel
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

5.  Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya.

Authors:  Catherine Laine; Tabitha Mwangi; Claudette M Thompson; Jacktone Obiero; Marc Lipsitch; J Anthony G Scott
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

6.  Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin.

Authors:  B Spellerberg; E Rozdzinski; S Martin; J Weber-Heynemann; N Schnitzler; R Lütticken; A Podbielski
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

7.  Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation.

Authors:  Sheila Z Kimaro Mlacha; Anne Warira; Hellen Gatakaa; David Goldblatt; J Anthony G Scott
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.